Micromet Signs US$1 B BiTE® Antibody Collaboration with Amgen
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 7 (Table of Contents)
Published: 25 Jul-2011
DOI: 10.3833/pdr.v2011.i7.1511 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Micromet’s BiTE® (bi-specific T-cell engagers) antibody platform has now attracted the attention of Amgen...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS